FOLH1 and metastatic neoplasm: Ferdinandus et al. demonstrated in their study that included 1960 patients the validity of the EAU risk classification by confirming that EAU BCR high-risk groups have higher rates of metastatic disease on PSMA PET/CT than low-risk groups.